Gradientech Granted Trademark for QuickMIC from United States Patent and Trademark Office

Uppsala, August 29, 2019. Gradientech AB today announces the trademark approval from the United States Patent and Trademark Office (USPTO) for QuickMIC®, its diagnostic system for ultrarapid antibiotic susceptibility testing. The registered trademark (Reg. No. 5817189) covers two classes for goods and services: Chemical and biological reagents for medical and veterinary use (IC 005) and diagnostic apparatus and instruments for analyzing cellular responses for medical and veterinary use (IC 010).

Sara Thorslund, CEO of Gradientech, commented on QuickMIC's recent trademark status: "The registered trademark not only will protect our intellectual property, but it will also strengthen the reputation of our company and help customers distinguish QuickMIC from other products when we enter the clinical microbiology market with our innovative diagnostic system".

QuickMIC is already a registered trademark in Europe.

For further information, please contact:
Sara Thorslund, PhD, CEO Gradientech
Tel: +46 736 29 35 80
sara.thorslund@gradientech.se

About Gradientech
Gradientech is a diagnostics company developing the in vitro diagnostic QuickMIC® system, a new platform for antibiotic susceptibility testing based on phenotypic bacterial growth analysis. The system is expected to become the most rapid solution for determining appropriate antibiotic treatment of sepsis patients. Rapid antibiotic susceptibility testing is vital for increasing sepsis patient survival, reducing healthcare costs and lowering the spread of antibiotic resistance. www.gradientech.se